The data underlying the results presented in the study are available for public purchase from the US Agency for Healthcare Research and Quality's Health Care Utilization Project's Central Distributor (contact via <https://www.hcup-us.ahrq.gov/tech_assist/centdist.jsp>) for researchers who complete the online Data Use Agreement Training.

Introduction {#sec005}
============

Endometriosis is a chronic inflammatory condition characterized by hormonally responsive endometrial-like tissue that exists outside of the uterus \[[@pone.0222889.ref001]\]. It affects 6−10% of reproductive-age women and has a considerable impact on health-related quality of life \[[@pone.0222889.ref002]--[@pone.0222889.ref005]\]. Endometriosis can seriously impact mental health in a variety of ways, including not only the stress of dealing with its most common symptoms (chronic pain and infertility), but also the stigma and social implications of the disease \[[@pone.0222889.ref006]--[@pone.0222889.ref008]\]. The pathogenesis of endometriosis remains enigmatic but certainly includes immunologic and hormonal factors, including oxidative stress, and genetic susceptibility and epigenetic modifications \[[@pone.0222889.ref006],[@pone.0222889.ref009]--[@pone.0222889.ref011]\].

First-line therapies for endometriosis are usually medical management using non-steroidal anti-inflammatory drugs and estrogen-progestin combination medications \[[@pone.0222889.ref012]\]. Other pharmacologic treatment options include progestins, anti-progestins, gonadotropin-receptor hormone agonists or antagonists, and aromatase inhibitors \[[@pone.0222889.ref013],[@pone.0222889.ref014]\]. Surgical options most often include laparoscopic excision or ablation of lesions, hysterectomy, and/or oophorectomy \[[@pone.0222889.ref014]\]. Choice of surgical approach is influenced by patient preferences, family planning status, and disease severity \[[@pone.0222889.ref014]\]. Often a combination of medical and surgical management is necessary \[[@pone.0222889.ref014],[@pone.0222889.ref015]\].

Minimally invasive surgical options have been broadly recommended to reduce the burden on patients and the healthcare system \[[@pone.0222889.ref014]--[@pone.0222889.ref017]\]. Slow but steady response to this recommendation is evident; for example, the share of hysterectomies performed laparoscopically increased from 10% in 1997 to 29% in 2010 and 43% in 2013 \[[@pone.0222889.ref018]--[@pone.0222889.ref020]\]. A recent study of the American College of Surgeons National Surgical Quality Improvement Program database found that 30% of recorded hysterectomies for benign indications in 2015 were abdominal, while 16% were vaginal and 55% were laparoscopic \[[@pone.0222889.ref021]\]. The move towards minimally invasive gynecologic surgery has led to a greater proportion of outpatient procedures, shorter hospital stays, fewer complications, and faster recovery for patients \[[@pone.0222889.ref022]\], though inpatient surgery remains necessary for some patients.

Despite evidence that the number of inpatient gynecological procedures performed in the United States has decreased in recent years, little is known about the patients still receiving inpatient care for endometriosis. Accordingly, we evaluated patterns of inpatient care for endometriosis using a recent, nationally representative sample of inpatient admissions in the United States. We analyzed trends in resource use, outcomes, and patient characteristics to obtain a more complete picture of inpatient care even as treatment recommendations have shifted towards outpatient management.

Materials and methods {#sec006}
=====================

Data source {#sec007}
-----------

This pooled cross-sectional study used data from the Health Care Utilization Project National Inpatient Sample (NIS) collected by the Agency for Healthcare Research and Quality. The NIS is a publicly available data source that contains a random sample of discharges from all non-federal hospitals in the United States. It captures approximately 20% of all community-hospital discharges in the US and when weighted represents an estimated 35 million hospitalizations annually \[[@pone.0222889.ref023]\]. It relies on administrative billing records to collect information on patient demographic and insurance characteristics, geographic location, International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis and procedure codes, total charges, and hospital characteristics. NIS data were collected based on a complex sampling design. Prior to 2012, annual stratified random samples of hospitals were identified, and 100% of discharges were collected from these hospitals. In 2012, the NIS design changed to sampling at the discharge level \[[@pone.0222889.ref024]\]. NIS data are publicly available and completely de-identified. Thus, their use does not constitute Human Subjects Research under the United States Federal Policy for the Protection of Human Subjects (the Common Rule) 45 CFR part 46, and consideration of this study by an Institutional Review Board is not required.

Sample {#sec008}
------

We obtained data from three mutually exclusive time periods that defined our cohorts: 2006--2007, 2010--2011, and 2014 through the third quarter of 2015, after which the NIS switched from ICD-9-CM to International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes. Inpatient admissions were identified with a principal diagnosis code of endometriosis (ICD-9-CM codes 617.xx). Women were excluded if they were younger than 18 years or older than 49 years old at admission, or if they had a diagnosis code for malignant neoplasms of female genital organs (ICD-9-CM codes 179 and 180.0--184.9), to increase the likelihood that observed procedures were being performed strictly for endometriosis management.

Variables {#sec009}
---------

Variables of interest included patient and hospital characteristics for each time-period-defined cohort. We also assessed the prevalence of 29 Elixhauser chronic comorbid conditions, which are commonly used to measure disease burden and case mix in hospital discharge data \[[@pone.0222889.ref025]\]. We calculated the prevalence of seven surgical procedures commonly associated with endometriosis management across time-period-defined cohorts: hysterectomy, laparoscopy, laparotomy, oophorectomy, bladder interventions, salpingectomy, and other excisions/ablations (see [S1 Table](#pone.0222889.s001){ref-type="supplementary-material"} for a list of procedures and their codes). Finally, we evaluated trends in surgical complications (see [S2 Table](#pone.0222889.s002){ref-type="supplementary-material"} for a list of complications and their codes), length of inpatient hospital stay, and total hospital charges. Total charges were inflated to 2015 US dollars using the Personal Health Care Price Index for Hospital Care \[[@pone.0222889.ref026]\].

Analyses {#sec010}
--------

Descriptive statistics for each time-period-defined cohort were calculated as counts and percentages for categorical variables and means for continuous variables. Unadjusted proportions and means were compared across time-period-defined cohorts using Pearson chi-squared tests or ANOVA tests. Missing values were reported as a separate category where relevant. All analyses were weighted to provide nationally representative estimates. For data prior to 2012, we used the NIS sample trend weights \[[@pone.0222889.ref027]\], whereas for subsequent years we used the cross-sectional weights. The weighting produced a large sample size in addition to nationally representative estimates; thus, results should be interpreted in terms of clinical as well as statistical significance.

Results {#sec011}
=======

For women with endometriosis as identified by an ICD-9-CM diagnosis code, the final sample consisted of 101,733 inpatient admissions for the 2006--07 cohort, 60,080 for the 2010--11 cohort, and 27,630 for the 2014--15 cohort ([Fig 1](#pone.0222889.g001){ref-type="fig"}).

![Sample selection protocol.\
Sample sizes are based on weighted national estimates; numbers may not add due to rounding.](pone.0222889.g001){#pone.0222889.g001}

Patient and hospital characteristics are presented by time-period-defined cohort in [Table 1](#pone.0222889.t001){ref-type="table"}.

10.1371/journal.pone.0222889.t001

###### Patient and hospital characteristics of women with an inpatient admission for endometriosis (ICD-9 code 617.xx) within time-period-defined cohorts.

![](pone.0222889.t001){#pone.0222889.t001g}

                                                                                                      Cohort (defined by years)                                                                         
  --------------------------------------------------------------------------------------------------- --------------------------- --------------------- ----------------------------------------------- -----------------------------------------------
                                                                                                      2006--07                    2010--11              2014--15[\*](#t001fn002){ref-type="table-fn"}   P-Value[^†^](#t001fn003){ref-type="table-fn"}
  Weighted Sample Size[^‡^](#t001fn004){ref-type="table-fn"}                                          101,733                     60,080                27,630                                           
                                                                                                      (%) of total cohort         (%) of total cohort   (%) of total cohort                             
  Variable                                                                                                                                                                                              
  Age                                                                                                                                                                                                   
      18--29 Years                                                                                    13.4%                       14.2%                 14.2%                                           0.03
      30--39 Years                                                                                    40.4%                       41.6%                 41.5%                                            
      40--49 Years                                                                                    46.1%                       44.2%                 44.3%                                            
  Payer Type                                                                                                                                                                                            
      Private                                                                                         79.3%                       71.8%                 66.1%                                           \<0.001
      Medicaid                                                                                        10.7%                       15.6%                 22.0%                                            
      Uninsured                                                                                       3.3%                        4.7%                  4.3%                                             
      Medicare and Other                                                                              6.5%                        7.7%                  7.3%                                             
      Missing                                                                                         0.2%                        0.2%                  0.2%                                            
  Elixhauser Comorbidity[^§^](#t001fn005){ref-type="table-fn"} Count                                                                                                                                    
      Zero                                                                                            59.9%                       53.8%                 48.8%                                           \<0.001
      One                                                                                             26.0%                       27.2%                 28.4%                                            
      Two                                                                                             9.9%                        12.2%                 13.9%                                            
      Three or More                                                                                   4.2%                        6.8%                  8.9%                                             
  National Quartile of ZIP Code-level Median Household Income[^‖^](#t001fn006){ref-type="table-fn"}                                                                                                     
      First                                                                                           21.4%                       22.7%                 26.6%                                           0.005
      Second                                                                                          26.7%                       24.8%                 25.9%                                            
      Third                                                                                           26.4%                       27.8%                 24.6%                                            
      Fourth                                                                                          23.6%                       23.0%                 21.0%                                            
      Missing                                                                                         1.9%                        1.7%                  1.8%                                             
  Race/Ethnicity[^¶^](#t001fn007){ref-type="table-fn"}                                                                                                                                                   
      White Non-Hispanic                                                                              50.5%                       60.5%                 57.7%                                           \<0.001
      Black Non-Hispanic                                                                              6.2%                        10.1%                 13.8%                                            
      Hispanic                                                                                        7.3%                        10.6%                 14.7%                                            
      Other Non-Hispanic                                                                              4.5%                        6.9%                  8.7%                                             
      Missing/Not Reported                                                                            31.5%                       11.9%                 5.1%                                             
  Hospital Census Region                                                                                                                                                                                 
      Northeast                                                                                       13.5%                       14.8%                 17.3%                                           0.06
      Midwest                                                                                         25.8%                       23.1%                 21.6%                                            
      South                                                                                           38.7%                       37.8%                 37.4%                                            
      West                                                                                            22.0%                       24.3%                 23.8%                                            
  Hospital Bed Size Category[^\#^](#t001fn008){ref-type="table-fn"}                                                                                                                                      
      Small                                                                                           13.8%                       11.3%                 16.9%                                           \<0.001
      Medium                                                                                          25.0%                       25.8%                 30.7%                                            
      Large                                                                                           61.1%                       61.7%                 52.4%                                            
      Missing                                                                                         0.1%                        1.2%                  0.0%                                             
  Hospital Location/Teaching Category                                                                                                                                                                    
      Rural                                                                                           13.1%                       13.1%                 11.1%                                           \<0.001
      Urban-NonTeaching                                                                               46.2%                       42.7%                 25.2%                                            
      Urban-Teaching                                                                                  40.6%                       43.0%                 63.7%                                            
      Missing                                                                                         0.1%                        1.2%                  0.0%                                             

Abbreviation: ICD-9: International Classification of Diseases, 9^th^ edition

\* Data for 2015 cover Q1-Q3 only.

^†^ P-values are from Pearson chi-squared tests that account for survey design.

^‡^ Weighted counts are nationally representative.

^**§**^ Elixhauser comorbidities are based on a roster of 29 comorbidities using ICD-9 diagnosis codes.^23^

^**‖**^ The first quartile corresponds to ZIP Codes with median household income below the 25^th^ percentile; the fourth corresponds to ZIP Codes above the 75^th^ percentile.

^¶^ The HCUP NIS combines race and Hispanic ethnicity into a single measure.

^**\#**^ Hospital bed-size categories were defined differently based on hospital geographic location, urban/rural, and teaching/non-teaching designation (see: <https://www.hcup-us.ahrq.gov/db/vars/hosp_bedsize/nisnote.jsp>).

Overall, the number of inpatient admissions for endometriosis decreased over the 10-year period studied and did so at a faster rate than inpatient admissions for all conditions, which were essentially flat at between 35 and 38 million admissions ([Fig 2](#pone.0222889.g002){ref-type="fig"}). There were also notable changes in the composition of patient and hospital characteristics of inpatient admissions for endometriosis. A higher percentage of inpatient admissions for endometriosis had Medicaid insurance coverage in the 2014--15 cohort compared to 2006--07 (22.0% vs 10.7%). Further, the proportion of women receiving endometriosis-related inpatient care who lived in ZIP Codes with a median income in the lowest quartile nationally increased over time, although more modestly (from 21.4% in 2006--07 to 26.6% in 2014--15). Patient comorbidity burden also increased over time. In 2006--07, 59.9% of admissions had no Elixhauser comorbidities compared with 48.4% in 2014--15. The percentage of admissions with ≥ 3 comorbidities doubled from 2006--07 to 2014--15 (4.2% vs 8.9%).

![Nationally representative endometriosis inpatient admission rates and total inpatient admissions trends, 2006--2015.\
Bars represent the annual endometriosis-related inpatient admission rate per 100,000; solid line represents total inpatient admissions in millions.](pone.0222889.g002){#pone.0222889.g002}

There were also changes in the characteristics of hospitals at which inpatient admissions for endometriosis occurred. In 2014--15, most patients were admitted to urban-teaching hospitals (62.7% in 2014--15 vs. 40.6% in 2006--07 and 43.0% in 2010--11; p\<0.001). [Table 2](#pone.0222889.t002){ref-type="table"} describes the prevalence of Elixhauser comorbidities within the three time-period-defined cohorts. There were differences in the prevalence of many comorbidities across cohorts, including hypertension (10.6%, 12.5%, and 14.7% for 2006--07, 2010--11, and 2014--15, respectively, p\<0.001) and drug abuse (0.5%, 1.0% and 1.3% for 2006--07, 2010--11, and 2014--15, respectively, p\<0.001).

10.1371/journal.pone.0222889.t002

###### Trends in the prevalence of comorbidities among women with an inpatient admission for endometriosis (ICD-9 code 617.xx) within time-period-defined cohorts.

![](pone.0222889.t002){#pone.0222889.t002g}

                                                                            Cohort (defined by years)                                                         
  ------------------------------------------------------------------------- --------------------------- --------------------- --------------------- --------- ---------
  Weighted Sample Size[^‡^](#t002fn004){ref-type="table-fn"}                101,733                     60,080                27,630                          
  AHRQ Elixhauser Comorbidities[^**§**^](#t002fn005){ref-type="table-fn"}   (%) of total cohort         (%) of total cohort   (%) of total cohort             
      Congestive heart failure                                              0.1%                        0.1%                  0.3%                  0.009     0.002
      Valvular disease                                                      1.9%                        1.3%                  0.9%                  \<0.001   \<0.001
      Pulmonary circulation disorders                                       0.1%                        0.2%                  0.2%                  0.41      0.30
      Peripheral vascular disorders                                         0.1%                        0.1%                  0.2%                  0.14      0.08
      Hypertension                                                          10.6%                       12.5%                 14.7%                 \<0.001   \<0.001
      Paralysis                                                             0.1%                        0.2%                  0.2%                  0.61      0.70
      Other neurological disorders                                          1.4%                        1.8%                  2.4%                  \<0.001   \<0.001
      Chronic pulmonary disease                                             8.1%                        9.6%                  10.3%                 \<0.001   \<0.001
      Diabetes, uncomplicated                                               3.2%                        4.0%                  4.7%                  \<0.001   \<0.001
      Diabetes with chronic complications                                   0.1%                        0.2%                  0.3%                  0.03      0.010
      Hypothyroidism                                                        4.9%                        5.9%                  6.4%                  \<0.001   \<0.001
      Renal failure                                                         0.2%                        0.2%                  0.5%                  \<0.001   \<0.001
      Liver disease                                                         0.3%                        0.4%                  0.6%                  \<0.001   \<0.001
      Peptic ulcer disease excluding bleeding                               0.004%                      0.02%                 0%                    0.35      0.60
      Acquired immune deficiency syndrome                                   0.02%                       0.04%                 0.02%                 0.43      0.97
      Lymphoma                                                              0.05%                       0.01%                 0.04%                 0.19      0.77
      Metastatic cancer                                                     0.04%                       0.03%                 0.1%                  0.79      0.55
      Solid tumor without metastasis                                        0.2%                        0.2%                  0.2%                  0.57      0.33
      Rheumatoid arthritis/collagen vascular diseases                       0.9%                        1.2%                  1.3%                  0.008     0.010
      Coagulopathy                                                          0.4%                        0.5%                  0.9%                  \<0.001   \<0.001
      Obesity                                                               6.10%                       9.4%                  13.3%                 \<0.001   \<0.001
      Weight loss                                                           0.1%                        0.3%                  0.5%                  \<0.001   \<0.001
      Fluid and electrolyte disorders                                       1.8%                        3.0%                  3.6%                  \<0.001   \<0.001
      Chronic blood loss anemia                                             3.3%                        2.1%                  2.2%                  \<0.001   \<0.001
      Deficiency anemias                                                    6.2%                        8.2%                  10.4%                 \<0.001   \<0.001
      Alcohol abuse                                                         0.1%                        0.3%                  0.3%                  0.005     0.005
      Drug abuse                                                            0.5%                        1.0%                  1.3%                  \<0.001   \<0.001
      Psychoses                                                             1.5%                        2.2%                  2.6%                  \<0.001   \<0.001
      Depression                                                            7.3%                        10.2%                 9.9%                  \<0.001   \<0.001

Abbreviations: ICD-9: International Classification of Diseases, 9^th^ edition; AHRQ: Agency for Healthcare Research and Quality

\* Data for 2015 cover Q1-Q3 only.

^†^ P-values are from ANOVA tests of equality that accounted for survey design.

^‡^ Weighted counts are nationally representative.

^**§**^ Elixhauser comorbidities were constructed using ICD-9 diagnosis codes.

There were also changes in the frequency of endometriosis-associated surgical procedures across the decade ([Table 3](#pone.0222889.t003){ref-type="table"}). The proportion of inpatient admissions that involved a hysterectomy changed from 78.2% in 2006--07 to 67.4% in 2014--15 (p\<0.001). The prevalence of laparoscopy remained at approximately 3% in all three time periods. Overall, the proportion of inpatient admissions with a primary diagnosis of endometriosis that included any of the seven endometriosis-related surgeries decreased over time, from 95.5% in 2006--07 to 91.1% in 2014--15. Among those without an endometriosis-related surgery of interest, over the full study period 46% had no surgery and 54% had another type of surgery.

10.1371/journal.pone.0222889.t003

###### Trends in surgical procedures reported in inpatients visits for endometriosis across cohorts.

![](pone.0222889.t003){#pone.0222889.t003g}

                                                               Cohort (defined by years)                                                         
  ------------------------------------------------------------ --------------------------- --------------------- --------------------- --------- ---------
  Weighted Sample Size[^‡^](#t003fn003){ref-type="table-fn"}   101,733                     60,080                27,630                          
  Surgical Procedure[^§^](#t003fn004){ref-type="table-fn"}     (%) of total cohort         (%) of total cohort   (%) of total cohort             
      Hysterectomy                                             78.2%                       74.1%                 67.4%                 \<0.001   \<0.001
      Bladder Intervention                                     0.4%                        0.5%                  0.4%                  0.98      0.93
      Laparoscopy                                              2.5%                        2.4%                  3.0%                  0.06      0.04
      Laparotomy                                               11.2%                       11.0%                 13.1%                 0.004     0.002
      Oophorectomy                                             62.9%                       60.1%                 58.3%                 \<0.001   \<0.001
      Other Excision/Ablation                                  8.2%                        10.2%                 11.9%                 \<0.001   \<0.001
      Salpingectomy                                            1.0%                        1.5%                  2.7%                  \<0.001   \<0.001
      Any of the Above Surgeries                               95.9%                       93.9%                 91.1%                 \<0.001   \<0.001

\* Data for 2015 cover Q1-Q3 only.

^†^ P-values are from ANOVA tests of equality that accounted for survey design.

^‡^ Weighted counts are nationally representative.

^**§**^ These seven categories of surgical procedures were selected as the most common surgical procedure types used for endometriosis management.

[Table 4](#pone.0222889.t004){ref-type="table"} reports trends in surgical complications by surgery type, length of inpatient stay, and total hospital charges. The prevalence of complications increased over time following hysterectomy, laparoscopy, and oophorectomy. While length of inpatient stay increased by \<1 day, there was a large increase in total charges (in 2015 USD) from \$22,642 in 2006--2007 to \$39,662 in 2014--2015 (p\<0.001).

10.1371/journal.pone.0222889.t004

###### Trends in surgical complications, total charges and inpatient length of stay across cohorts.

![](pone.0222889.t004){#pone.0222889.t004g}

                                                                                            Cohort (defined by years)                                                         
  ----------------------------------------------------------------------------------------- --------------------------- --------------------- --------------------- --------- ---------
  Weighted Sample Size[^‡^](#t004fn004){ref-type="table-fn"}                                101,733                     60,080                27,630                          
                                                                                            (%) of total cohort         (%) of total cohort   (%) of total cohort             
  Prevalence of Complications by Surgical Procedure[^§^](#t004fn005){ref-type="table-fn"}                                                                                     
      Hysterectomy                                                                          12.4%                       13.3%                 15.3%                 \<0.001   \<0.001
      Bladder Intervention                                                                  12.1%                       10.2%                 17.4%                 0.61      0.47
      Laparoscopy                                                                           15.2%                       17.6%                 24.0%                 0.053     0.016
      Laparotomy                                                                            15.3%                       16.8%                 19.9%                 0.02      0.005
      Oophorectomy                                                                          13.7%                       14.3%                 16.6%                 0.001     \<0.001
      Other Excision/Ablation                                                               17.0%                       16.8%                 18.7%                 0.59      0.38
      Salpingectomy                                                                         17.6%                       16.1%                 12.8%                 0.46      0.21
      Any of the Above Surgeries                                                            12.9%                       13.8%                 16.0%                 \<0.001   \<0.001
  Mean Length of Stay (Days)                                                                2.4                         2.3                   2.6                   \<0.001   0.013
  Mean Total Charges per Stay (2015 USD)                                                    22,642                      30,977                39,662                \<0.001   \<0.001

Abbreviation: USD: United States Dollars

\* Data for 2015 covers Q1-Q3 only.

^†^ P-values are from ANOVA tests of equality that accounted for survey design.

^‡^ Weighted counts are nationally representative.

^**§**^ These seven categories of surgical procedures were selected as the most common surgical procedure types used for endometriosis management.

Discussion {#sec012}
==========

Principal findings {#sec013}
------------------

During 2006--2015 the number of inpatient admissions for endometriosis decreased. Although hysterectomy and oophorectomy remained the predominant inpatient surgical procedures observed, their prevalence declined slightly. The prevalence of surgical complications increased overall and by procedure type. Average length of stay increased slightly, and total hospital charges increased considerably.

The composition of women being admitted for endometriosis changed over the same period. Higher proportions of women in later cohorts had multiple comorbidities, were covered by Medicaid as opposed to commercial insurance, and lived in lower-income ZIP Codes. This raises the possibility that, as inpatient admissions for endometriosis have become less common, women who are admitted for endometriosis have fewer resources and are at higher risk than women who receive care in other, presumably outpatient, settings.

Prior research suggests women with fewer resources and more comorbidities are more likely to receive a hysterectomy \[[@pone.0222889.ref028]\]. Further, there is compelling evidence that patients with higher income, private insurance, and white race are more likely to undergo laparoscopic hysterectomy versus open hysterectomy \[[@pone.0222889.ref019],[@pone.0222889.ref021],[@pone.0222889.ref029]\]. These trends are increasingly visible in inpatient endometriosis care. This is especially concerning as endometriosis-associated symptoms can recur following hysterectomy \[[@pone.0222889.ref030]\]; thus, vulnerable patients may incur higher risks for procedures that do not confer higher benefits.

Increased complications and patient comorbidities may have helped drive the increases in hospital charges. Between 2003 and 2014 the percentage of inpatient admissions with multiple chronic conditions increased from 64% to 78%, with the fastest growth among patients aged 18--44 years \[[@pone.0222889.ref031]\]. This suggests that patient complexity continues to be an important consideration when evaluating inpatient care, especially regarding associated resource use and costs.

Clinical implications {#sec014}
---------------------

Our study draws attention to an important population of patients: those who continued to receive inpatient care for endometriosis even as management guidelines emphasized minimally invasive care. It is important to monitor this population of women to ensure that women who receive inpatient treatment are only those who are indicated for it, to guard against disparities based on non-clinical factors such as income, education, geographic location, or race/ethnicity. It is also important to assess the population currently requiring inpatient care to inform efforts to reduce the need for inpatient care in the future, indeed even among women for whom it may be indicated today.

Additionally, there are important economic implications to our study that are relevant to clinical care. Given that the associated mean total charges per stay increased, inpatient care---particularly surgical care---remains an important contributor to the overall economic burden of endometriosis. Total costs of surgery for endometriosis are high and include complications, medical management during recovery and follow-up, and the possibility of retreatment in addition to the cost of the procedure \[[@pone.0222889.ref032],[@pone.0222889.ref033]\]. Endometriosis-related surgery is also associated with considerable indirect costs in the form of increased absenteeism and presents a significant economic burden to society \[[@pone.0222889.ref034]\]. Inpatient costs, and the economic burden of endometriosis overall, may continue to rise if vulnerable patients, including those with multiple comorbidities, are preferentially directed towards invasive procedures requiring inpatient care.

Research implications {#sec015}
---------------------

Our findings add an important and objective assessment of national trends in the still sizeable number of inpatient procedures that occur for endometriosis even as guidelines recommend outpatient care settings when possible. Current outpatient medical management of endometriosis may also affect inpatient care and deserves further study. As the number of inpatient admissions related to endometriosis decreased over time, patients who received inpatient care for endometriosis were increasingly at higher risk and more disadvantaged. This may be indicative of the lack of access of vulnerable populations to timely and effective medical management or outpatient surgical care, though this would need to be confirmed with a corresponding analysis of outpatient data. Our study also provides an important characterization of the comorbidities associated with patients who are receiving inpatient care for endometriosis, which could be important information for hospitals seeking to improve inpatient endometriosis care. Finally, we observed contemporaneous increases in hospital charges and length of stay as well as surgical complications. The growth in hospital charges over 2006--2015 continues an earlier rising trend reported in an analysis of HCUP NIS data for 1993--2002; in contrast, while declining from 1993 to 2000, length of stay has not changed much since then \[[@pone.0222889.ref035]\]. Limitations in the currently available data preclude us from going beyond describing the national trends; future research is needed to explore potential explanations.

Strengths and limitations {#sec016}
-------------------------

Our study used the NIS database, which consists of a random sample of non-federal hospitals that, when weighted, produces a nationally representative estimate of US inpatient admissions. The NIS database has several limitations, however. It includes only individuals who received inpatient healthcare services. Also, it does not follow individual women over time or cover healthcare use outside of inpatient hospitalizations. Thus, the full scope of endometriosis-related care, including outpatient procedures, is not captured. The study period ended in 2015, and practice patterns may have changed since then, although many of the changes observed were modest across the decade captured in this study. Only the first three quarters of 2015 were analyzed because of the change to ICD-10-CM coding and the associated risk of diagnosis and procedure misclassification \[[@pone.0222889.ref036]\].

Moreover, the NIS database, as is true of all large ICD-based data capture, is limited because it is based on administrative data that are collected primarily for billing and reimbursement. It offers limited detail about clinical decision-making, patient complexity, and other important aspects of the clinical encounter. The NIS data may suffer from coding inaccuracies as well as inconsistencies across hospitals. There are likely missed endometriosis-related procedures, particularly when endometriosis was present but not coded. It is also possible that patients are being incorrectly diagnosed with endometriosis, particularly if diagnoses are based on clinical symptoms. These coding patterns can vary informatively by clinician specialty and patient and hospital characteristics. In addition, the NIS reports hospital charges, which represent neither reimbursed amounts nor the costs faced by hospitals.

Of particular importance to the study of endometriosis, the NIS does not contain information about endometriosis stage nor certain details about the surgical procedures performed in terms of the intensity of dissection required. Unfortunately, given a lack of standardization of surgical documentation, it is currently not possible to abstract this information from any form of medical records across multiple practitioners within or among surgical sites \[[@pone.0222889.ref037]\]. All forms of endometriosis are challenging to treat; however, surgical complexity and requirement for advanced expertise is particularly high for deep endometriosis. Techniques such as superficial and deep rectal shaving and nerve sparing intestinal dissection are important considerations \[[@pone.0222889.ref038]--[@pone.0222889.ref041]\]. Future studies will require standardized collection of these endometriosis phenotypic presentation and surgical approach details to parse out adequately whether there has been shift over time in inpatient procedures toward women with more surgically complex endometriosis presentation that may have previously been mis- or undiagnosed.

An obvious restriction in scope of our analysis is that it examines endometriosis surgical treatment only in the inpatient setting; the inpatient setting is the focus of our review to allow characterization of this population. These findings should not be generalized to those receiving care in the outpatient surgery setting. Endometriosis treatment recommendations have focused on increasing the use of outpatient surgery (for example, laparoscopic lesion ablation/excision, ovarian cystectomy for endometriomas, and lysis of adhesions \[[@pone.0222889.ref042]\]), and recent data suggest that outpatient surgery has become commonplace. For 29 states with administrative data on all inpatient admissions and ambulatory surgery visits, 78.0% of endometriosis cases in 2014 were treated in an ambulatory surgery setting \[[@pone.0222889.ref043]\]. Unfortunately, there is no nationally representative database of outpatient visits corresponding to the HCUP NIS that we could use to assess treatment patterns overall and compare trends in treatment patterns between care settings. There are several possible explanations for our observed trends in inpatient management, including case selection for inpatient surgery to those with more complex presentation, associated comorbidities that do not allow the patient to receive care at an outpatient surgery center (e.g., body mass index), or changes in documentation such as altered ICD code attribution. Because there is no corresponding outpatient national dataset available, we are unable to explore which factors may be contributing to our observations.

Conclusions {#sec017}
-----------

Surgery is an important clinical option for endometriosis, and it remains central to classifying the disease \[[@pone.0222889.ref037]\]. However, minimally invasive approaches should be prioritized. Because of its serious personal and societal implications, tracking clinical outcomes, economic burden and health disparities associated with endometriosis is critical to ensure that all women have access to appropriate treatment.

Supporting information {#sec018}
======================

###### Surgical procedures and corresponding ICD-9 diagnosis and procedure codes included in the analysis.
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Click here for additional data file.

###### Surgical complications and corresponding ICD-9 diagnosis and procedure codes included in the analysis.
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Click here for additional data file.
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